27049318|t|The Influence of Perioperative Dexmedetomidine on Patients Undergoing Cardiac Surgery: A Meta-Analysis.
27049318|a|BACKGROUND: The use of dexmedetomidine may have benefits on the clinical outcomes of cardiac surgery. We conducted a meta-analysis comparing the postoperative complications in patients undergoing cardiac surgery with dexmedetomidine versus other perioperative medications to determine the influence of perioperative dexmedetomidine on cardiac surgery patients. METHODS: Randomized or quasi-randomized controlled trials comparing outcomes in patients who underwent cardiac surgery with dexmedetomidine, another medication, or a placebo were retrieved from EMBASE, PubMed, the Cochrane Library, and Science Citation Index. RESULTS: A total of 1702 patients in 14 studies met the selection criteria among 1,535 studies that fit the research strategy. Compared to other medications, dexmedetomidine has combined risk ratios of 0.28 (95% confidence interval [CI] 0.15, 0.55, P = 0.0002) for ventricular tachycardia, 0.35 (95% CI 0.20, 0.62, P = 0.0004) for postoperative delirium, 0.76 (95% CI 0.55, 1.06, P = 0.11) for atrial fibrillation, 1.08 (95% CI 0.74, 1.57, P = 0.69) for hypotension, and 2.23 (95% CI 1.36, 3.67, P = 0.001) for bradycardia. In addition, dexmedetomidine may reduce the length of intensive care unit (ICU) and hospital stay. CONCLUSIONS: This meta-analysis revealed that the perioperative use of dexmedetomidine in patients undergoing cardiac surgery can reduce the risk of postoperative ventricular tachycardia and delirium, but may increase the risk of bradycardia. The estimates showed a decreased risk of atrial fibrillation, shorter length of ICU stay and hospitalization, and increased risk of hypotension with dexmedetomidine.
27049318	31	46	Dexmedetomidine	Chemical	MESH:D020927
27049318	50	58	Patients	Species	9606
27049318	127	142	dexmedetomidine	Chemical	MESH:D020927
27049318	249	276	postoperative complications	Disease	MESH:D011183
27049318	280	288	patients	Species	9606
27049318	321	336	dexmedetomidine	Chemical	MESH:D020927
27049318	420	435	dexmedetomidine	Chemical	MESH:D020927
27049318	455	463	patients	Species	9606
27049318	545	553	patients	Species	9606
27049318	589	604	dexmedetomidine	Chemical	MESH:D020927
27049318	750	758	patients	Species	9606
27049318	883	898	dexmedetomidine	Chemical	MESH:D020927
27049318	990	1013	ventricular tachycardia	Disease	MESH:D017180
27049318	1056	1078	postoperative delirium	Disease	MESH:D000071257
27049318	1119	1138	atrial fibrillation	Disease	MESH:D001281
27049318	1179	1190	hypotension	Disease	MESH:D007022
27049318	1236	1247	bradycardia	Disease	MESH:D001919
27049318	1262	1277	dexmedetomidine	Chemical	MESH:D020927
27049318	1419	1434	dexmedetomidine	Chemical	MESH:D020927
27049318	1438	1446	patients	Species	9606
27049318	1511	1534	ventricular tachycardia	Disease	MESH:D017180
27049318	1539	1547	delirium	Disease	MESH:D003693
27049318	1578	1589	bradycardia	Disease	MESH:D001919
27049318	1632	1651	atrial fibrillation	Disease	MESH:D001281
27049318	1723	1734	hypotension	Disease	MESH:D007022
27049318	1740	1755	dexmedetomidine	Chemical	MESH:D020927
27049318	Negative_Correlation	MESH:D020927	MESH:D003693
27049318	Negative_Correlation	MESH:D020927	MESH:D011183
27049318	Positive_Correlation	MESH:D020927	MESH:D001919
27049318	Negative_Correlation	MESH:D020927	MESH:D001281
27049318	Negative_Correlation	MESH:D020927	MESH:D017180
27049318	Association	MESH:D020927	MESH:D000071257
27049318	Positive_Correlation	MESH:D020927	MESH:D007022

